Cosciens Biopharma Inc.
CSCI
Revenue
2.75M
▲1.25M▲83.27%
3 Months ChangeAssets
27.56M
▼-3.58M▼-11.51%
3 Months ChangeLiabilities
20.46M
▼-536.00k▼-2.55%
3 Months ChangeFree Cash Flow
-4.50M
▼-2.00M▼-80.20%
3 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-03-27
Form 20-F
ID: 0001493152-24-011401
2023-03-23
Form 20-F
ID: 0001493152-23-008641
2022-03-29
Form 20-F
ID: 0001493152-22-007933
2021-03-25
Form 40-F
ID: 0001493152-21-006745
2020-03-31
Form 20-F
ID: 0001493152-20-005347
2019-04-01
Form 20-F
ID: 0001628280-19-003681
2018-03-28
Form 20-F
ID: 0001628280-18-003635
2017-03-16
Form 20-F
ID: 0001113423-17-000010
2016-03-30
Form 20-F
ID: 0001113423-16-000039
2015-03-17
Form 20-F
ID: 0001113423-15-000004